Hypericum extract WS^® 5570 for depression – An overview

References

• Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M. 2006. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study. Pharmacopsychiatry 39:213–219.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA. 1984. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365–1367.
   PubMed Web of Science ®Google Scholar
• Benazzi F. 1998. Weight gain in depression remitted with antide-pressants: Pharmacological or recovery effect? Psychother Psychosom 67:271–274.
   Google Scholar
• Bernd A, Simon S, Ramirez Bosca A, Kippenberger S, Diaz Alperi J, Miquel J, et al. 1999. Phototoxic effects of Hypericum extract in cultures of human keratinocytes compared with those of psoralen. Photochem Photobiol 69:218–221.
   PubMed Web of Science ®Google Scholar
• Borrelli F, Izzo AA. 2009. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J 11:710–727.
   PubMed Web of Science ®Google Scholar
• Butterweck V. 2003. Mechanism of action of St John's wort in depression: what is known? CNS Drugs 17:539–562.
   PubMed Web of Science ®Google Scholar
• Butterweck V, Schmidt M. 2007. St. John's wort: role of active compounds for its mechanism of action and efficacy. Wien Med Wochenschr 157:356–361.
   PubMedGoogle Scholar
• Caraci F, Crupi R, Drago F, Spina E. 2011. Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract. Curr Drug Metab 12:570–577.
   PubMed Web of Science ®Google Scholar
• Carpenter C, Crigger N, Kugler R, Loya A. 2008. Hypericum and nurses: a comprehensive literature review on the efficacy of St. John's Wort in the treatment of depression. J Holist Nurs 26:200–207 ; discussion 208–211.
   PubMedGoogle Scholar
• Carpenter DJ. 2011. St. John's wort and S-adenosyl methionine as “natural” alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit? Altern Med Rev 16:17–39.
   Google Scholar
• Clement K, Covertson CR, Johnson MJ, Dearing K. 2006. St. John's wort and the treatment of mild to moderate depression: a systematic review. Holist Nurs Pract 20:197–203.
   PubMedGoogle Scholar
• Committee on Herbal Medicinal Products (HMPC). 2009. Community herbal monograph on Hypericum perforatol L., herba (well-established medicinal use). London, UK: European Medicines Agency . Report nr EMA/HMPC/101304/2008.
   Google Scholar
• Ernst E. 2009. Review: St John's wort superior to placebo and similar to antidepressants for major depression but with fewer side effects. Evid Based Ment Health 12:78.
   Google Scholar
• Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, Mischoulon D. 2010. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. J Clin Psychiatry 71:669–681.
   PubMed Web of Science ®Google Scholar
• Gaster B, Holroyd J. 2000. St John's wort for depression: a systematic review. Arch Intern Med 160:152–156.
   PubMed Web of Science ®Google Scholar
• Grundmann O, Lv Y, Kelber O, Butterweck V. 2010. Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system.Neuropharmacology 58:767–773.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296.
   PubMed Web of Science ®Google Scholar
• Hammerness P, Basch E, Ulbricht C, Barrette EP, Foppa I, Basch S, et al.;Natural Standard Research Collaboration. 2003. St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist.Psychosomatics 44:271–282.
   PubMed Web of Science ®Google Scholar
• Härter M, Klesse C, Bermejo I, Bschor T, Gensichen J, Harfst T, et al. 2010. Evidenzbasierte therapie der depression: Die S3-Leitlinie unipolare depression. Nervenarzt 81:1049–1068.
   PubMed Web of Science ®Google Scholar
• Izzo AA. 2004. Drug interactions with St. John's Wort (Hypericum perforatum): A review of the clinical evidence. Int J Clin Pharmacol Ther 42:139–148.
   PubMed Web of Science ®Google Scholar
• Izzo AA, Ernst E. 2009. Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs 69:1777–1798.
   PubMed Web of Science ®Google Scholar
• Kasper S. 2001. Hypericum perforatum – A review of clinical studies. Pharmacopsychiatry 34:S51–S55.
   PubMed Web of Science ®Google Scholar
• Kasper S, Anghelescu I, Szegedi A, Dienel A, Kieser M. 2006. Superior efficacy of St John's wort extract WS® 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial. BMC Med 4:14.
   PubMed Web of Science ®Google Scholar
• Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M. 2007. Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode. Wien Med Wochenschr 157:362–366.
   PubMedGoogle Scholar
• Kasper S, Caraci F, Forti B, Drago F, Aguglia E. 2010a. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. Eur Neuropsychopharmacol 20:747–765.
   PubMed Web of Science ®Google Scholar
• Kasper S, Dienel A. 2002. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology 164:301–308.
   Google Scholar
• Kasper S, Gastpar M, Möller HJ, Müller WE, Volz HP, Dienel A, Kieser M. 2010b. Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. Int Clin Psychopharmacol 25:204–213.
   PubMed Web of Science ®Google Scholar
• Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Kieser M, Möller HJ. 2008a. Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. Eur Arch Psychiatry Clin Neurosci 258:59–63.
   PubMed Web of Science ®Google Scholar
• Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Möller HJ. 2008b. Behandlung depressiver Störungen mit Johanniskraut WS® 5570 - Kein Einfluss auf das Patientengewicht. Psychophar-makotherapie 15:6–10.
   Google Scholar
• Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M. 2008c. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression–a double-blind, randomized, placebo controlled long-term trial. Eur Neuropsychopharmacol 18:803–813.
   PubMed Web of Science ®Google Scholar
• Knüppel L, Linde K. 2004. Adverse effects of St. John's Wort: a systematic review. J Clin Psychiatry 65:1470–1479.
   PubMed Web of Science ®Google Scholar
• Länger R. 2010. Die HMPC-Monographie zu Hypericum: Hintergründe, Entstehung, Inhalte. Wien Med Wochenschr 160:557–563.
   Google Scholar
• Lecrubier Y, Clerc G, Didi R, Kieser M. 2002. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 159:1361–1366.
   PubMed Web of Science ®Google Scholar
• Levitt AJ, Joffe RT, Esche I, Sherret D. 1987. The effect of desipramine on body weight in depression. J Clin Psychiatry 48:27–28.
   Google Scholar
• Linde K. 2009. St. John's wort – an overview. Forsch Komplementmed16:146–155.
   Google Scholar
• Linde K, Berner MM, Kriston L. 2008. St John's wort for major depression. Cochrane Database Syst Rev 8:CD000448.
   Google Scholar
• Linde K, Knüppel L. 2005. Large-scale observational studies of hypericum extracts in patients with depressive disorders–A systematic review. Phytomedicine 12:148–157.
   PubMed Web of Science ®Google Scholar
• McIntyre M. 2000. A review of the benefits, adverse events, drug interactions, and safety of St. John's Wort (Hypericum perforatum): The implications with regard to the regulation of herbal medicines. J Altern Complement Med 6:115–124.
   Google Scholar
• Montgomery SA. 1995. Safety of mirtazapine: a review. Int Clin Psychopharmacol 10:37–45.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389.
   PubMed Web of Science ®Google Scholar
• Müller WE. 2003. Current St John's wort research from mode of action to clinical efficacy. Pharmacol Res 47:101–109.
   PubMed Web of Science ®Google Scholar
• Nahrstedt A, Butterweck V. 2010. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular). J Nat Prod 73:1015–1021.
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health. 1970. 12 - CGI. Clinical Global Impressions. In: Guy W, editor. EDCEU assessment in psychopharmacology. Rockville, MD: U.S. National Institute of Mental Health, Psychopharmacology Research Branch. pp 217–222.
   Google Scholar
• Nieuwstraten C, Labiris NR, Holbrook A. 2006. Systematic overview of drug interactions with antidepressant medications. Can J Psychiatry 51:300–316.
   PubMed Web of Science ®Google Scholar
• Paykel ES. 1983. The classification of depression. Br J Clin Pharmacol 15:155S–159S.
   Google Scholar
• Prenner L, Sieben A, Zeller K, Weiser D, Haberlein H. 2007. Reduction of high-affinity beta2-adrenergic receptor binding by hyper-forin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy. Biochemistry 46:5106–5113.
   Google Scholar
• Ravindran AV, Lam RW, Filteau MJ, Lesperance F, Kennedy SH,Parikh SV, Patten SB; Canadian Network for Mood Anxiety Treatments (CANMAT). 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord 117:S54–S64.
   Google Scholar
• Rodriguez-Landa JF, Contreras CM. 2003. A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine 10:688–699.
   PubMed Web of Science ®Google Scholar
• Schellander R, Donnerer J. 2010. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology 86:203–215.
   PubMed Web of Science ®Google Scholar
• Schulz HU, Schurer M, Bassler D, Weiser D. 2006. Investigation of the effect on photosensitivity following multiple oral dosing of two different hypericum extracts in healthy men. Arzneimittelforschung 56:212–221.
   Google Scholar
• Schulz V. 2006. Safety of St. John's Wort extract compared to synthetic antidepressants. Phytomedicine 13:199–204.
   PubMed Web of Science ®Google Scholar
• Solomon D, Ford E, Adams J, Graves N. 2011. Potential of St John's Wort for the treatment of depression: the economic perspective. Aust N Z J Psychiatry 45:123–130.
   PubMed Web of Science ®Google Scholar
• Szegedi A, Kohnen R, Dienel A, Kieser M. 2005. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 330:503–506.
   PubMed Web of Science ®Google Scholar
• Trautmann-Sponsel RD, Dienel A. 2004. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials. J Affect Disord 82:303–307.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Sherbourne CD. 1992. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483.
   Google Scholar
• Whiskey E, Werneke U, Taylor D. 2001. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol 16:239–252.
   PubMed Web of Science ®Google Scholar
• Wurglics M, Westerhoff K, Kaunzinger A, Wilke A, Baumeister A, Dressman J, Schubert-Zsilavecz M. 2001a. Batch-to-batch reproducibility of St. John's wort preparations. Pharmacopsychiatry 34:S152–S156.
   PubMedGoogle Scholar
• Wurglics M, Westerhoff K, Kaunzinger A, Wilke A, Baumeister A, Dressman J, Schubert-Zsilavecz M. 2001b. Comparison of German St. John's wort products according to hyperforin and total hypericin content. J Am Pharm Assoc (Wash) 41:560–566.
   PubMedGoogle Scholar